Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Browne, D. L
Right arrow Articles by Cummings, M. H
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Vasodilator prostanoids compensate for attenuated nitric oxide mediated vasodilation in type 1 diabetes

Duncan L Browne

Academic Department of Diabetes and Endocrinology, Queen Alexandra Hospital, Cosham, Portsmouth, PO6 3LY. UK

Darryl R Meeking

Academic Department of Diabetes and Endocrinology, Queen Alexandra Hospital, Cosham, Portsmouth, PO6 3LY. UK

Sharon Allard

Academic Department of Diabetes and Endocrinology, Queen Alexandra Hospital, Cosham, Portsmouth, PO6 3LY. UK

Linda J Munday

Academic Department of Diabetes and Endocrinology, Queen Alexandra Hospital, Cosham, Portsmouth, PO6 3LY. UK

Kenneth M Shaw

Academic Department of Diabetes and Endocrinology, Queen Alexandra Hospital, Cosham, Portsmouth, PO6 3LY. UK

Michael H Cummings

Academic Department of Diabetes and Endocrinology, Queen Alexandra Hospital, Cosham, Portsmouth, PO6 3LY. UK, michael.cummings{at}porthosp.nhs.uk

Background Previous research examining endothelial function and the biochemical pathways mediating vasodilation in type 1 diabetes has been conflicting. Both impaired and preserved nitric oxide (NO) mediated vasodilation have been reported whilst some authors have suggested enhanced vasodilator prostanoid (P) activity. The aim of this study was to determine the relative contributions of NO and P to endothelial function in a homogenous group of type 1 diabetic patients free of other confounding factors that may influence vascular behaviour.^f ^

Methods and results Endothelial function was assessed using forearm venous plethysmography in 16 patients with uncomplicated type 1 (duration of diabetes 16.8±2.5 years (mean±SEM), HbA1C 7.53±0.21% ) and 15 non-diabetic age and sex matched healthy control subjects. Forearm responses to the endothelium-dependent vasodilator, acetylcholine (ACh) (7.5, 15 and 30 µg/min), were recorded at baseline and after intra-arterial infusion of L-NMMA (a NO synthase inhibitor). Responses to ACh were re-examined following co-infusion of L-NMMA and indomethacin (a cyclo-oxygenase inhibitor). Responses to ACh were calculated as areas under the curve (AUC). At baseline vasodilator responses to ACh were similar (p=0.3) in diabetic and non-diabetic subjects. However, L-NMMA reduced ACh mediated responses to a lesser extent in diabetic subjects than control subjects (3±6% versus 18±3%; p<0.03 respectively). Co-infusion with indomethacin further reduced blood flow, but the relative decrease in AUC was greater in the diabetic group (28±3% vs. 14±3%; p<0.001). The contribution of biochemical pathways other than NO and P were similar in both diabetic and control groups (69±7% vs. 68±4%; p=0.45).

Conclusions Vasodilator responses to ACh were unchanged in type 1 diabetes but this was reliant up on enhanced P mediated activity compensating for attenuated NO activity. Furthermore, vasoactive substances in addition to NO and P contribute significantly to vascular tone in both diabetic and non-diabetic subjects.

Key Words: acetylcholine • endothelium • nitric oxide • prostaglandins • type 1 diabetes.

References

  • Krolewski AS, Kosinski EJ, Warram JH et al. Magnitude and Determinants of Coronary Artery Disease in Juvenile-Onset, Insulin-Dependent Diabetes Mellitus. Am J Cardiol 1987;59:750-5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet ii 1989:997-1000.
  • Calver A., Collier J., Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992;90:2548-54.[Web of Science][Medline] [Order article via Infotrieve]
  • Abrams J. Role of endothelial dysfunction in coronary artery disease. Am J Cardiol 1997;79(12B):2-9.[Web of Science][Medline] [Order article via Infotrieve]
  • Neunteufl T., Heher S., Katzenschlager R. et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000;86:207-10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Meeking DR, Browne DL, Allard S. et al. Effects of cyclo-oxygenase inhibition on vasodilatory response to acetylcholine in patients with type 1 diabetes and nondiabetic subjects. Diabetes Care 2000;23:1840-3.[Abstract/Free Full Text]
  • Wotherspoon F., Laight DW, Browne DL et al. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria. Diabetic Med 2006;23:1350-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • O'Driscoll G., Green D., Rankin J. et al. Improvements in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest 1997;100:678-84.[Web of Science][Medline] [Order article via Infotrieve]
  • Johnstone MT, Creager SJ, Scales KM et al. Impaired endothelium-dependent vasodilatation in patients with insulin-dependent diabetes mellitus. Circulation 1993:88:2510-16.[Abstract/Free Full Text]
  • Stehouwer CD, Lambert J., Donker AJ, van Hinsbergh VW Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997;34(1):55-68.[Abstract/Free Full Text]
  • Elliott TG, Cockcroft JR, Groop P-H. et al. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 1993;85:687-93.[Web of Science][Medline] [Order article via Infotrieve]
  • O'Byrne SO, Forte P., Roberts J. et al. Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes 2000;49:857-62.[Abstract]
  • Duffy SJ, New G., Tran BT et al. Relative contribution of vasodilator prostanoids and NO to metabolic vasodilation in the human forearm. Am J Physiol 1999;276(2 Pt 2):H663-H670.[Web of Science][Medline] [Order article via Infotrieve]
  • Tesfamariam B., Brown ML, Deykin D., Cohen RA Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 1990;85:929-32.[Web of Science][Medline] [Order article via Infotrieve]
  • Dogra G., Rich L., Stanton K., Watts GF Endothelium-dependent and independent vasodilation studied at normoglycaemia in Type 1 diabetes mellitus with and without microalbuminuria. Diabetologia 2001;44:593-601.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arterial tone in man. Lancet 1989; 2:997-1000.[Web of Science][Medline] [Order article via Infotrieve]
  • Dawes M., Chowienczyk PJ, Ritter JM Effects of inhibition of Tthe Larginine / nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. Circulation 1997;95:2293-7.[Abstract/Free Full Text]
  • Timimi FK, Ting HH, Hayley et al. Vitamin C improves G endotheliumdependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998;31:552-7.[Abstract/Free Full Text]
  • Macklin AV, Viberti GC, Ritter J. Forearmblood Y flow in type 1 diabetics during systemic hyperglycemia. Diabetologia 1998;41(1):A310.
  • Rubanyi GM, McKinney M., Vanhoutte PM Biphas A ic release of endothelium-derived relaxing factor(s) by acetylcholine from perfused canine femoral arteries. Characterisation of muscurinic receptors. J Pharmacol Exp Ther 1987;240:802-08. OD[Abstract/Free Full Text]
  • Chan NN, Vallance P., Colhoun HM Nitric oxide and vascular responses in Type I diabetes. Diabetologia 2000;43:137-47.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • van Veen S., Chang PC Prostaglandin and nitric oxide mediate insulininduced vasodilation in the human forearm. Cardiovasc Res 1997;34:223-9.[Abstract/Free Full Text]
  • Dawes M., Chowienczyk PJ, Ritter JM Quantitative aspects of the inhibition by N(G)-monomethyl-L-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature. Br J Pharmacol 2001;134:939-44.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Skyrme-Jones Rap, O'Brien RC, Meredith IT Vasodilator prostanoids, but not nitric oxide, may account for skeletal muscle hyperaemia in Type 1 diabetes mellitus. Clinical Science 2000;99:383-92.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Schade DS, Eaton RP, Freidman N., Spencer W. The intravenous, intraperitoneal and subcutaneous routes of insulin delivery in diabetic man. Diabetes 1979;28:1069-72.[Medline] [Order article via Infotrieve]
  • Gonzalez E., Rosello-Catafau J., Jawerbaum A. et al. Involvement of inducible isoforms of COX and NOS in streptozotocin-pancreatic damage in the rat: interactions between nitridergic and prostanoid pathway. Prostaglandins Leukot Essent Fatty Acids 2001;64:311-16.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Honing MLH, Smits P., Morrison PJ et al. Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarisation. Hypertension 2000; 35:1314-18.[Abstract/Free Full Text]
  • Taddei S., Versari D., Cipriano A. et al. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. JACC 2006;48:508-15.[Abstract/Free Full Text]
  • Rajagopalan S., Kurz S., Munzel T. et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations in vasomotor tone. J Clin Invest 1996;97:1916-23.[Web of Science][Medline] [Order article via Infotrieve]
  • Cardillo C., Kilcoyne CM, Cannon RO Det al. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo. Hypertension 2000;35:1237-41.[Abstract/Free Full Text]
  • Drury PL, Smith GM, Ferriss JB Increased vasopressor responsiveness to angiotensin II in type 1(insulin dependent) diabetic patients without complications. Diabetologia 1984;27:174-9.[Web of Science][Medline] [Order article via Infotrieve]
  • McIntyre C., Hadoke PWF, Williams BC et al. Selective enhancement of sensitivity to endothelin-1 despite normal endothelium-dependent relaxation in subcutaneous resistance arteries isolated from patients with Type 1 diabetes. Clinical Science 2001;100:311-18.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Butler R., Morris AD, Burchell B., Struthers AD DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension 1999;33:1164-8.dysnction in normal J, humans, Hypertension T. Gene transfer of endothelial[Abstract/Free Full Text]
  • Zanetti M., Sato J., Katusic ZS, O'Brien T. Gene transfer of endothelial nitric oxide synthase alters endothelium-dependent relaxations in aortas from diabetic rabbits. Diabetologia 2000;43:340-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bush DE, Jones CE, Bass KM et al. Estrogen replacement reverses endothelial dysfunction in postmenopausal women. Am J Med 1998;104:552-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ishii H., Jirousek MR, Koya D. et al. Amelioration of vascular dysfunction in diabetic rats by an oral PKC-beta inhibitor. Science 1996;272:728-31.[Abstract]
  • Mutus B., Rabini RA, Staffolani R. et al. Homocysteine-induced inhibition of nitric oxide production study on healthy and diabetic subjects. Diabetologia 2001;44:979-82.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

The British Journal of Diabetes & Vascular Disease, Vol. 7, No. 6, 288-294 (2007)
DOI: 10.1177/14746514070070060601
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Browne, D. L
Right arrow Articles by Cummings, M. H
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?